NCT07538414

Brief Summary

Retrospective Single-center Analysis of Patients Presenting With Acute Neurological Symptoms, Aiming to Characterize the Frequency, Clinical Features, Diagnostic Pathways, and Healthcare Utilization of Patients with Functional Neurological Diseases

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
299mo left

Started Mar 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

March 30, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 20, 2026

Completed
24.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2050

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2050

Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

24.7 years

First QC Date

March 30, 2026

Last Update Submit

April 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of FND

    The primary endpoint is the proportion of patients presenting with acute neurological symptoms who receive a diagnosis or likely differential diagnosis of Functional Neurological Disorder (FND) during their index hospital admission.

    At hospital discharge (index admission), up to 30 days from presentation

Secondary Outcomes (8)

  • Secondary Outcomes

    At hospital discharge (index admission), up to 30 days from presentation

  • Secondary Outcomes

    At hospital discharge (index admission), up to 30 days from presentation

  • Secondary Outcomes

    At hospital discharge (index admission), up to 30 days from presentation

  • Secondary Outcomes

    At hospital discharge (index admission), up to 30 days from presentation

  • Secondary Outcomes

    At hospital discharge (index admission), up to 30 days from presentation

  • +3 more secondary outcomes

Interventions

collection of patient data

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients presenting with acute symptoms

You may qualify if:

  • Patients older than 16 years old presenting as an emergency case to the University Hospital Basel between 1 January 2012 and 31 March 2026
  • with acute neurological symptoms requiring immediate neurological work-up (e.g, acute motor or sensory disturbance, acute speech disorder, acute vestibular disorder, acute cognitive disorder, acute consciousness disorder, acute seizure disorder)
  • and a documented diagnostic evaluation during hospitalization.

You may not qualify if:

  • Documented refusal for further use of health related data for research purposes
  • Insufficient documentation to determine diagnosis or clinical course
  • Incomplete or inconsistent datasets compromising valid endpoint determination
  • Younger than 16 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Basel

Basel, 4031, Switzerland

RECRUITING

MeSH Terms

Conditions

Conversion Disorder

Condition Hierarchy (Ancestors)

Somatoform DisordersMental Disorders

Central Study Contacts

Urs Fisch, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 30, 2026

First Posted

April 20, 2026

Study Start

March 30, 2026

Primary Completion (Estimated)

December 1, 2050

Study Completion (Estimated)

December 1, 2050

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations